Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Veltassa
| Field | Information |
|---|---|
| Medication Name | Veltassa |
| Generic Name | Patiromer |
| Boxed/Label Warning | May bind to some other orally administered medications, reducing their absorption. Separate administration from other oral medications by at least 3 hours. |
| Purpose | Treats hyperkalemia (high potassium levels in the blood) |
| Mechanism of Action | Binds potassium in the gastrointestinal tract, reducing its absorption into the bloodstream. |
| Dosage Forms | Oral powder for suspension |
| Available Strengths | 8.4 g, 16.8 g, 25.2 g per packet |
| Dosage Frequency | Usually once daily, but can be increased to three times daily if needed, based on potassium levels and doctor’s instructions. |
| Common Side Effects | Constipation, nausea, diarrhea, abdominal discomfort, flatulence |
| Serious Side Effects | Hypomagnesemia (low magnesium levels), intestinal obstruction, worsening of heart failure symptoms due to sodium retention. |
| Drug Interactions | Many; Separate from other oral medications by at least 3 hours. Consider interactions with drugs like digoxin, warfarin, and certain antibiotics. |
| Important Notes | Monitor potassium and magnesium levels regularly. Can cause constipation, consider a stool softener. Use with caution in patients with heart failure due to sodium content. |
| Storage | Store at room temperature away from moisture and heat. |
| Missed Dose | Take as soon as you remember, unless it is close to your next dose. Do not double the dose. |
| Alternatives | Sodium Polystyrene Sulfonate (Kayexalate), Lokelma (sodium zirconium cyclosilicate), Dietary Modifications |
Veltassa Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Sodium Polystyrene Sulfonate (Kayexalate) | Binds potassium in the intestine, exchanging it for sodium. | Older medication, may cause significant constipation. |
| Lokelma (sodium zirconium cyclosilicate) | Binds potassium in the gastrointestinal tract. | Similar mechanism to Veltassa; may have a faster onset of action. |
| Dietary Modifications | Reduced potassium intake. | Important adjunctive measure, but often not sufficient alone for significant hyperkalemia. |
Veltassa Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Constipation | Hypomagnesemia (low magnesium levels) |
| Nausea | Intestinal obstruction |
| Diarrhea | Worsening of heart failure symptoms (edema, shortness of breath) |
| Abdominal discomfort | Allergic reactions (rash, itching, swelling) |
| Flatulence | Electrolyte imbalances (beyond potassium and magnesium) |
Veltassa Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Hyperkalemia | 8.4 g once daily | 8.4 g to 25.2 g once daily, adjusted based on potassium levels. | Mix with water and stir well before drinking. Separate from other oral medications by at least 3 hours. |
Veltassa Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $20 – $200 |
| Without Insurance (U.S.) | $1200 |
| From Canada | $615 |
